一般財団法人化学及血清療法研究所が製造販売するインフルエンザHAワクチンについて｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000101868.html一般財団法人化学及血清療法研究所が製造販売するインフルエンザHAワクチンについて｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page is a Ministry of Health, Labour and Welfare announcement regarding influenza HA vaccine manufactured by the Chemical and Serum Therapeutic Research Institute. The institute had failed to properly report discrepancies between approval documents and actual manufacturing practices, leading to a shipment suspension request in September. After review, authorities determined the vaccine's quality and safety were not significantly affected. The Infectious Diseases Division of the Health Science Council recommended approving shipments to prevent supply shortages and control influenza. Consequently, the shipment suspension was lifted on October 21, 2015.
